AAV2 vectors and methods

Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S456000, C435S320100, C435S069100, C435S091410, C424S093200, C424S199100, C536S023100, C800S003000

Reexamination Certificate

active

06962815

ABSTRACT:
The invention relates to Adeno-associated virus vectors. In particular, it relates to Adeno-associated virus vectors with modified capsid proteins and materials and methods for their preparation and use.

REFERENCES:
patent: WO00/28004 (2000-05-01), None
Chiorini et al. Cloning of Adeno-Associated Virus Type 4 (AAV4) and Generation of Recombinant AAV4 Particles. Journal of Virology. p. 6823-6833, Sep. 1997.
Kronenberg et al, Electron cryo-associated microscopy and image reconstruction of adeno-associated virus type 2 empty capsids, 2001, EMBO reports, vol. 21 (11) pp. 997-1002.
Srivastava, et al., Nucleotide Sequence and Organization of the Adeno-Associated Virus 2 Genome,Journal of Virology45 (2): 555-564 (Feb. 1983).
Ruffing et al., Mutations in the carboxy terminus of adeno-associated virus 2 capsid proteins affect viral infectivity: lack of an RGD integrin-binding motif,Journal of General Virology75: 3385-3392 (1994).
Hermonat et al., Genetics of Adeno-Associated Virus: Isolation and Preliminary Characterization of Adeno-Associated Virus Type 2 Mutants,Journal of Virology51 (2): 329-339 (Aug. 1984).
Santiago et al., New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury,Nature Medicine5 (11): 1264-1269 (Nov. 1999).
Muzyczka, Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells,Current Topics in Microbiology and Immunology158: 97-129 (1992).
Girod et al., Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2,Nature Medicine5 (9): 1052-1056 (Sep. 1999).
Rabinowitz et al., Insertional Mutagenesis of AAV2 Capsid and the Production of Recombinant Virus,Virology265: 274-285 (1999).
Tsao et al., The Three-Dimensional Structure of Canine Parvovirus and Its Functional Implications,Science251: 1456-1464 (Mar. 1991).
Wu et al., The Canine Parvovirus Empty Capsid Structure,J. Mol. Biol.233 (2): 231-244 (1993),
Agbandje et al., Structure Determination of Feline Panleukopenia Virus Empty Particles,Proteins16: 155-171 (Jun. 1993).
Agbandje-McKenna et al., Functional implications of the structure of the murine parvovirus, minute virus of mice,Structure6 (11): 1369-1381 (Nov. 1998).
Llamas-Saiz et al., Structure Determination of Minute Virus of Mice,Acta Crystallographica Section DD53: 93-102 (1997).
Chipman et al., Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor,Proc. Natl. Acad. Sci. USA93: 7502-7506 (Jul. 1996).
McKenna et al., Three-Dimensional Structure of Aleutian Mink Disease Parvovirus: Implications for Disease Pathogenicity,Journal of Virology73 (8): 6882-6891 (Aug. 1999).
Wu et al., Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism,Journal of Virology74 (18): 8635-8647 (Sep. 2000).
Shi et al., Insertional Mutagenesis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Generation of AAV2 Vectors Targeted to Alternative Cell-Surface Receptors,Human Gene Therapy, 12: 1697-1711 (Sep. 2001).
Bartlett et al., Infectious Entry Pathway of Adeno-Associated Virus and Adeno-Associated Virus Vectors.Journal of Virology, 74(6): 2777-2785 (1999).
Kigawa et al., Adenovirus-mediated Transfer of a p53 Gene in Ovarian Cancer,Adv. Exp. Med. Biol. 465(14): 207-14 (2000).
Song et al., In vivo Studies of Adenovirus-mediated p53 Gene Therapy for Cis-platinum-Resistent Human Ovarian Tumor Xenografts,Oncol. Res., 11(3): 153-159m (1999).
Yamaguchi et al., Co-transfection of Herpes Simplex Virus Thymidine Kinase Gene and Human Interleukin-2 Gene into Mouse Ovarian Cancer Cell Line, OVHM,Intl. J. Mol. Med., 6(2): 185-190 (2000).
Genbank Accession No. AF043303, Adeno-Associated Virus 2 (Feb. 24, 1998).
Wu et al., “Mutational Analysis Of The Adano-Associated Virus Type 2 (AAV2) Capsid Gene And Construction of AAV2 Vactors With Altered Tropism,”Journal Of Virology, 74(18): 8635-8647 (Sep. 2000).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

AAV2 vectors and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with AAV2 vectors and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and AAV2 vectors and methods will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3486610

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.